Snehal Patel
Vermogen: 147 M $ op 31-05-2026
Vermogen: 147 M $ op 31-05-2026
Snehal S.
Patel is currently Director, Chief Executive & Financial Officer at Greenwich LifeSciences, Inc. since 2016 and has been with the company since 2010.
Mr. Patel is also VP-Operations at Welspun Corp.
Ltd. Education includes an undergraduate degree from Massachusetts Institute of Technology and an MBA from The University of Chicago.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 26-05-2026 | 5.604.102 ( 40,45% ) | 147 M $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| GREENWICH LIFESCIENCES, INC. | Algemeen Directeur | 01-06-2016 |
| WELSPUN CORP LIMITED | Operationeel Directeur | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 4 |
|---|---|
Welspun Corp. Ltd.
Welspun Corp. Ltd. Industrial MachineryProducer Manufacturing Manufactures steel pipes, coils and plates | Producer Manufacturing |
Massachusetts Institute of Technology
Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
The University of Chicago
The University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Greenwich LifeSciences, Inc.
Greenwich LifeSciences, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops immunotherapy to prevent breast cancer recurrences | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau